Table 3.
Summary of primary and comorbid conditions reported by 53,963 patients seeking medical cannabis certification across five states
| Condition | Massachusetts n = 27,892 n (%) |
Colorado n = 16,434 n (%) |
Maine n = 4591 n (%) |
Connecticut n = 2643 n (%) |
Maryland n = 2403 n (%) |
Total n = 61,379 % |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary condition | |||||||||||
| Chronic pain | 5407 | (19.4%) | 12926 | (78.7%) | 1646 | (35.9%) | 42 | (1.6%) | 569 | (23.7%) | 38.8% |
| Anxiety | 6062 | (21.7%) | 5 | (<0.1%) | 581 | (12.7%) | 9 | (0.3%) | 487 | (20.3%) | 13.5% |
| Post-traumatic stress disorder | 1439 | (5.2%) | 456 | (2.8%) | 323 | (7.0%) | 1860 | (70.4%) | 126 | (5.2%) | 8.4% |
| Back and neck problems | 2737 | (9.8%) | 22 | (0.1%) | 590 | (12.9%) | 24 | (0.9%) | 273 | (11.4%) | 6.5% |
| Arthritis | 1785 | (6.4%) | 14 | (0.1%) | 232 | (5.1%) | 44 | (1.7%) | 142 | (5.9%) | 3.9% |
| Insomnia | 1811 | (6.5%) | 1 | (0.0%) | 169 | (3.7%) | 0 | (0.0%) | 76 | (3.2%) | 3.4% |
| Cancer-related pain | 752 | (2.7%) | 447 | (2.7%) | 84 | (1.8%) | 98 | (3.7%) | 48 | (2.0%) | 2.7% |
| Depression | 1050 | (3.8%) | 0 | (0.0%) | 58 | (1.3%) | 0 | (0.0%) | 102 | (4.2%) | 2.0% |
| Migraines | 810 | (2.9%) | 26 | (0.2%) | 136 | (3.0%) | 36 | (1.4%) | 54 | (2.2%) | 2.0% |
| Muscle spasms | 148 | (0.5%) | 780 | (4.7%) | 32 | (0.7%) | 0 | (0.0%) | 26 | (1.1%) | 1.7% |
| ADD/ADHD | 866 | (3.1%) | 0 | (0.0%) | 71 | (1.5%) | 0 | (0.0%) | 39 | (1.6%) | 1.6% |
| Chronic nausea | 248 | (0.9%) | 546 | (3.3%) | 60 | (1.3%) | 0 | (0.0%) | 16 | (0.7%) | 1.5% |
| Fibromyalgia | 448 | (1.6%) | 14 | (0.1%) | 57 | (1.2%) | 53 | (2.0%) | 28 | (1.2%) | 1.2% |
| Headaches | 292 | (1.0%) | 242 | (1.5%) | 94 | (2.0%) | 29 | (1.1%) | 15 | (0.6%) | 1.2% |
| Spinal cord injury/disease | 263 | (0.9%) | 0 | (0.0%) | 15 | (0.3%) | 192 | (7.3%) | 22 | (0.9%) | 0.9% |
| Other | 3774 | (13.5%) | 955 | (5.8%) | 443 | (9.6%) | 256 | (9.7%) | 380 | (15.8%) | 10.7% |
| Comorbid Conditions | |||||||||||
| Anxiety | 9815 | (35.2%) | 1226 | (7.5%) | 1543 | (33.6%) | 1534 | (58.0%) | 710 | (29.5%) | 28.3% |
| Back and neck problems | 7858 | (28.2%) | 1642 | (10.0%) | 1323 | (28.8%) | 807 | (30.5%) | 564 | (23.5%) | 23.7% |
| Depression | 8290 | (29.7%) | 481 | (2.9%) | 1059 | (23.1%) | 1014 | (38.4%) | 560 | (23.3%) | 21.9% |
| Insomnia | 9442 | (33.9%) | 740 | (4.5%) | 1157 | (25.2%) | 782 | (29.6%) | 491 | (20.4%) | 23.2% |
| Chronic pain | 6227 | (22.3%) | 1072 | (6.5%) | 1314 | (28.6%) | 653 | (24.7%) | 584 | (24.3%) | 18.2% |
| Stress | 7171 | (25.7%) | 73 | (0.4%) | 913 | (19.9%) | 947 | (35.8%) | 571 | (23.8%) | 11.2% |
| Headaches | 4569 | (16.4%) | 1339 | (8.1%) | 756 | (16.5%) | 487 | (18.4%) | 277 | (11.5%) | 14.2% |
| Arthritis | 5013 | (18.0%) | 700 | (4.3%) | 767 | (16.7%) | 452 | (17.1%) | 286 | (11.9%) | 14.0% |
| Muscle spasms | 3234 | (11.6%) | 2141 | (13.0%) | 668 | (14.6%) | 331 | (12.5%) | 277 | (11.5%) | 12.8% |
| Migraines | 3508 | (12.6%) | 692 | (4.2%) | 392 | (8.5%) | 362 | (13.7%) | 189 | (7.9%) | 9.9% |
| Post-traumatic stress disorder | 3265 | (11.7%) | 1257 | (7.6%) | 618 | (13.5%) | 114 | (4.3%) | 201 | (8.4%) | 10.0% |
| ADD/ADHD | 2855 | (10.2%) | 88 | (0.5%) | 366 | (8.0%) | 377 | (14.3%) | 216 | (9.0%) | 7.5% |
| Mood disorders | 2222 | (8.0%) | 30 | (0.2%) | 261 | (5.7%) | 308 | (11.7%) | 140 | (5.8%) | 6.0% |
| Chronic nausea | 1544 | (5.5%) | 1665 | (10.1%) | 350 | (7.6%) | 0 | (0.0%) | 77 | (3.2%) | 7.2% |
| Neuropathic pain | 1660 | (6.0%) | 165 | (1.0%) | 253 | (5.5%) | 200 | (7.6%) | 96 | (4.0%) | 4.8% |
| Irritable bowel syndrome | 1698 | (6.1%) | 82 | (0.5%) | 292 | (6.4%) | 197 | (7.5%) | 83 | (3.5%) | 4.6% |
| Appetite stimulation | 1875 | (6.7%) | 112 | (0.7%) | 256 | (5.6%) | 157 | (5.9%) | 102 | (4.2%) | 4.7% |
| Fibromyalgia | 967 | (3.5%) | 189 | (1.2%) | 173 | (3.8%) | 83 | (3.1%) | 48 | (2.0%) | 2.9% |
| Spinal cord injury | 928 | (3.3%) | 27 | (0.2%) | 131 | (2.9%) | 105 | (4.0%) | 63 | (2.6%) | 2.7% |
| Obsessive compulsive behavior | 904 | (3.2%) | 11 | (0.1%) | 89 | (1.9%) | 132 | (5.0%) | 45 | (1.9%) | 2.3% |
Table 3 provides a summary of the reported primary and comorbid conditions of patients seeking medical cannabis access at CB2 Insights clinics between November 2018 and March 2020 across five states. The total column includes all 61,379 patients included in the initial study for comparison, including patients from 12 states (Mahabir et al. 2020). Patients could only report one primary condition. All conditions that represented at least 2.0% of the sample in one state are listed, the remaining are grouped under “other”. Patients could report multiple comorbid conditions, but not the same comorbid condition as their primary. The top 20 are reported in the table. ADD = attention deficit disorder; ADHD = attention deficit hyperactivity disorder